Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Glenmark Generics Inc, the US subsidiary of the Glenmark Generics Ltd, has received the US Food and drug administration's (FDA) approval for fluticasone propionate 0.05% lotion abbreviated new drug application (ANDA).
Subscribe to our email newsletter
Glenmark’s fluticasone propionate 0.05% lotion is the generic version of Nycomed US Cutivate lotion.
Cutivate (fluticasone propionate, 0.05%) lotion is a topical prescription medication for the relief of skin pain, redness and itching due to eczema in adults and in children one year of age and older.
Earlier, Nycomed has filed a lawsuit against Glenmark in December 2008, related to Glenmark’s ANDA for fluticasone propionate lotion.
If Glenmark successfully challenges Nycomed’s patent, it will be entitled to a 180-day exclusivity period.